Novel Pharmacological Approaches for Multidrug‐Resistant Tuberculosis: Review
Kassahun Dires Ayenew, Habtemariam Alekaw Habteweld, Abate Wondesen Tsige, Yihenew Sewale Bizu · 2025
Read Novel Pharmacological Approaches for Multidrug‐Resistant Tuberculosis: Review by Kassahun Dires Ayenew, Habtemariam Alekaw Habteweld, Abate Wondesen Tsige, Yihenew Sewale Bizu (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12664762.txt.
Description
Four Ethiopian reviewers argue that drug-resistant tuberculosis demands treatment built person by person. The resistant form shrugs off the standard drugs, so success depends on each patient's other illnesses, past treatment, and which drugs their strain still fears. The review gathers work on tailored plans, from drug-sensitivity testing and gene-based dosing clues to patient involvement in choices.
Testing the strain before choosing drugs proved essential for sound decisions. Genetic data on how a patient processes drugs can guide dose changes. Patients who help shape their plan stick with it better. New drug combinations raised cure chances while slowing new resistance, and close monitoring let doctors adjust quickly when a plan faltered. The authors close by urging research that joins these threads, including therapies aimed at the host's own defenses.
Catalog record
| CREATOR | Kassahun Dires Ayenew, Habtemariam Alekaw Habteweld, Abate Wondesen Tsige, Yihenew Sewale Bizu |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |